์•„์‹œํด๋กœ๋ฒ„ / Acyclovir

์ •์˜

Acyclovir๋Š” ๋Œ€์ƒํฌ์ง„ ์น˜๋ฃŒ์— ์‚ฌ์šฉํ•˜๋Š” ํ•ญ๋ฐ”์ด๋Ÿฌ์Šค์ œ์ด๋ฉฐ, ๊ฒฝ๊ตฌ ๋˜๋Š” ์ •์ฃผ ๊ฒฝ๋กœ๋กœ ํˆฌ์—ฌ๋  ์ˆ˜ ์žˆ๋‹ค. ์ด raw ์ž๋ฃŒ์˜ ํ•ต์‹ฌ์€ ๋Œ€์ƒํฌ์ง„์—์„œ ์–ธ์ œ IV acyclovir๋ฅผ ์„ ํƒํ• ์ง€์ด๋‹ค.

์ž„์ƒ ํ•ต์‹ฌ

Uncomplicated localized dermatomal zoster์—์„œ๋Š” ๋ณดํ†ต PO antiviral๋กœ ์ถฉ๋ถ„ํ•˜๋‹ค. IV acyclovir๋Š” severe/complicated zoster ๋˜๋Š” severely immunocompromised ํ™˜์ž์—์„œ ๊ณ ๋ คํ•œ๋‹ค. ์ƒˆ vesicle์ด ๊ณ„์† ์ƒ๊ธฐ๊ฑฐ๋‚˜ ๋ณ‘๋ณ€์ด ๋น ๋ฅด๊ฒŒ ์ง„ํ–‰ํ•˜๋Š” ๋ฉด์—ญ์ €ํ•˜ ํ™˜์ž๋Š” IV ์ชฝ์œผ๋กœ ๋ณธ๋‹ค.

์ง„๋‹จ

IV ํ•„์š”์„ฑ์„ ํŒ๋‹จํ•  ๋•Œ ๋ฉด์—ญ์ €ํ•˜ ์—ฌ๋ถ€, disseminated rash, eye/CNS/visceral ์นจ๋ฒ”, toxic appearance, PO ๊ฐ€๋Šฅ ์—ฌ๋ถ€๋ฅผ ํ™•์ธํ•œ๋‹ค. CNS ์นจ๋ฒ” ์˜์‹ฌ ์†Œ๊ฒฌ์€ AMS, focal neurologic deficit, severe headache, meningismus ๋“ฑ์ด๋‹ค. Visceral involvement ์˜์‹ฌ ์†Œ๊ฒฌ์€ hepatitis, pneumonitis, encephalitis/meningitis, myelitis, vasculopathy/stroke-like symptoms ๋“ฑ์ด๋‹ค.

์น˜๋ฃŒ

IV acyclovir ๊ณ ๋ ค ์ƒํ™ฉ: severe immunocompromise, disseminated zoster, visceral involvement, CNS/neurologic complication, severe/high-risk ophthalmic zoster, PO ๋ถˆ๊ฐ€/ํก์ˆ˜ ๋ฌธ์ œ, ์ž„์‹  ์ค‘ severe disease. Disseminated zoster์—์„œ๋Š” airborne/contact isolation, IV acyclovir, admission์„ ํ•จ๊ป˜ ๊ณ ๋ คํ•œ๋‹ค. ์šฉ๋Ÿ‰์€ renal function์— ๋”ฐ๋ผ ์กฐ์ •ํ•œ๋‹ค.

์ถœ์ฒ˜

CDC Shingles Clinical Overview; Merck Manual Professional Herpes Zoster.

๐ŸŒฑ ์ถœ์ฒ˜ raw


๋ณธ ๋ฌธ์„œ๋Š” ํ•™์Šตยท์ฐธ๊ณ ์šฉ์ด๋ฉฐ ์‹ค์ œ ์ง„๋ฃŒ ๊ฒฐ์ •์€ ์ž„์ƒ์˜์˜ ํŒ๋‹จ์ž…๋‹ˆ๋‹ค.